Inari Medical plans to buy LimFlow Medical for up to $415M
The Inari deal comes weeks after LimFlow won FDA premarket approval for its breakthrough system to treat chronic limb-threatening ischemia.
Source: massdevice.com
Fast, Ad-Free News Updates
Stay updated with breaking news from How Limflow. Real-time updates on events, politics, business and more.